KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Intangibles: 2009-2025

Historic Intangibles for Pacira BioSciences (PCRX) over the last 12 years, with Sep 2025 value amounting to $382.4 million.

  • Pacira BioSciences' Intangibles fell 13.15% to $382.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $382.4 million, marking a year-over-year decrease of 13.15%. This contributed to the annual value of $426.0 million for FY2024, which is 11.85% down from last year.
  • Pacira BioSciences' Intangibles amounted to $382.4 million in Q3 2025, which was down 9.51% from $422.6 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Intangibles registered a high of $624.0 million during Q4 2021, and its lowest value of $90.6 million during Q3 2021.
  • Moreover, its 3-year median value for Intangibles was $454.6 million (2024), whereas its average is $459.0 million.
  • In the last 5 years, Pacira BioSciences' Intangibles spiked by 546.46% in 2021 and then decreased by 14.36% in 2023.
  • Over the past 5 years, Pacira BioSciences' Intangibles (Quarterly) stood at $624.0 million in 2021, then declined by 13.37% to $540.5 million in 2022, then decreased by 10.60% to $483.3 million in 2023, then dropped by 11.85% to $426.0 million in 2024, then decreased by 13.15% to $382.4 million in 2025.
  • Its Intangibles was $382.4 million in Q3 2025, compared to $422.6 million in Q2 2025 and $435.0 million in Q1 2025.